RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Soliman, Karam F.
Item TypeName
Academic Article Diallyl disulfide inhibits TNFa-induced CCL2 release by MDA-MB-231 cells.
Academic Article Apigenin inhibits TNFa/IL-1a-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells.
Academic Article The inhibitory effects of plumbagin on the NF-?B pathway and CCL2 release in racially different triple-negative breast cancer cells.
Academic Article Whole Transcriptomic Analysis of Apigenin on TNFa Immuno-activated MDA-MB-231 Breast Cancer Cells.
Academic Article The inhibitory effects of butein on cell proliferation and TNF-a-induced CCL2 release in racially different triple negative breast cancer cells.
Concept Tumor Necrosis Factor-alpha
Concept Receptors, Tumor Necrosis Factor, Member 25
Academic Article Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells.
Academic Article Pentagalloyl glucose inhibits TNF-a-activated CXCL1/GRO-a expression and induces apoptosis-related genes in triple-negative breast cancer cells.
Academic Article Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
Academic Article Sanguinarine Inhibition of TNF-a-Induced CCL2, IKBKE/NF-?B/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
Academic Article Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-a-induced Triple Negative Breast Cancer Cells.
Academic Article Thymoquinone Inhibition of Chemokines in TNF-a-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.
Academic Article The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
Search Criteria
  • Lymphotoxin beta
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support